James F. Young, Director at NOVAVAX INC (NVAX), sold 10,000 shares at $8.00 ($82K) on 2024-12-31, disclosed to the SEC on 2025-01-02.
Open-market sale of $82k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.48 | 4,600 | $39K | 47.5% |
| 2 | $8.00 | 5,400 | $43K | 52.5% |
| Total | $8.22 avg | 10,000 | $82K | 100% |
| Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |
| NVAX | SELL | 2021-03-25 | $4.6M | — | Filing → |